炎症负担指数对急性心肌梗死患者PCI术后 左心室重构的预测价值
Predictive Value of Inflammatory Burden Index for Left Ventricular Remodeling in Patients with Acute Myocardial Infarction after PCI
摘要: 目的:探讨炎症负荷指数(IBI)对急性ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)术后左心室重构(LVR)的预测价值,并与传统炎症及肝功能指标进行比较。方法:回顾性纳入319例STEMI患者,根据PCI术后6个月及12个月心脏超声结果分为左心室重构组(n = 136)与非重构组(n = 183)。收集患者临床资料及实验室指标,计算炎症负荷指数(IBI),公式为:IBI = (CRP × 中性粒细胞计数)/淋巴细胞计数。采用单因素及多因素Logistic回归分析LVR的独立危险因素,并通过受试者工作特征(ROC)曲线评估各指标的预测效能。结果:左心室重构组IBI、C反应蛋白、肌酸激酶同工酶、谷丙转氨酶、谷草转氨酶水平显著高于非重构组(P < 0.05)。多因素Logistic回归分析显示,IBI (OR = 1.012, 95% CI: 1.000~1.024, P = 0.04)和谷丙转氨酶(OR = 1.011, 95% CI: 1.004~1.019, P < 0.01)是LVR的独立危险因素。ROC曲线分析表明,IBI的AUC为0.752,谷丙转氨酶的AUC为0.651,二者联合的AUC为0.750。当IBI最佳截断值取10.156时,预测LVR的敏感度为73.5%,特异度为63.4%,Youden指数为0.369。结论:炎症负荷指数是STEMI患者PCI术后左心室重构的独立预测因子,其预测效能优于传统单一炎症指标,与谷丙转氨酶联用未能进一步提高预测能力。当IBI > 10.156时,患者发生左心室重构的风险显著增加。IBI作为一种简便、易得的复合指标,可用于早期识别高危患者。
Abstract: Objective: To investigate the predictive value of the Inflammatory Burden Index (IBI) for left ventricular remodeling (LVR) in patients with acute ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI), and to compare its predictive performance with traditional inflammatory and liver function markers. Methods: A total of 319 STEMI patients were retrospectively enrolled and divided into the LVR group (n = 136) and non-LVR group (n = 183) based on echocardiographic findings at 6 and 12 months after PCI. Clinical data and laboratory indicators were collected. The IBI was calculated using the formula: IBI = (CRP × neutrophil count)/lymphocyte count. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for LVR. The predictive performance of each indicator was assessed using receiver operating characteristic (ROC) curves. Results: The levels of IBI, C-reactive protein (CRP), creatine kinase-MB (CK-MB), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were significantly higher in the LVR group than in the non-LVR group (all P < 0.05). Multivariate logistic regression analysis showed that IBI (OR = 1.012, 95% CI: 1.000~1.024, P = 0.04) and ALT (OR = 1.011, 95% CI: 1.004~1.019, P < 0.01) were independent risk factors for LVR. ROC curve analysis revealed that the area under the curve (AUC) of IBI was 0.752, that of ALT was 0.651, and that of their combination was 0.750. When the optimal cut-off value of IBI was set at 10.156, the sensitivity and specificity for predicting LVR were 73.5% and 63.4%, respectively, with a Youden index of 0.369. Conclusion: The Inflammatory Burden Index is an independent predictor of left ventricular remodeling in STEMI patients after PCI, with better predictive performance than traditional single inflammatory markers. Combining IBI with ALT did not further improve predictive ability. When IBI exceeds 10.156, the risk of LVR increases significantly. As a simple and easily accessible composite indicator, IBI can be used for early identification of high-risk patients.
文章引用:范建勇, 韩吉瑛, 宇成栋, 李鹏. 炎症负担指数对急性心肌梗死患者PCI术后 左心室重构的预测价值[J]. 临床医学进展, 2026, 16(5): 319-328. https://doi.org/10.12677/acm.2026.1651821

参考文献

[1] Leancă, S.A., Crișu, D., Petriș, A.O., Afrăsânie, I., Genes, A., Costache, A.D., et al. (2022) Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life, 12, Article 1111. [Google Scholar] [CrossRef] [PubMed]
[2] Swirski, F.K. and Nahrendorf, M. (2018) Cardioimmunology: The Immune System in Cardiac Homeostasis and Disease. Nature Reviews Immunology, 18, 733-744. [Google Scholar] [CrossRef] [PubMed]
[3] Siwik, D.A., Chang, D.L. and Colucci, W.S. (2000) Interleukin-1β and Tumor Necrosis Factor-Α Decrease Collagen Synthesis and Increase Matrix Metalloproteinase Activity in Cardiac Fibroblasts in Vitro. Circulation Research, 86, 1259-1265. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, L., Chen, M., Yang, X., Hu, Y., Qiu, C., Fu, Y., et al. (2025) Energy Metabolism in Cardiovascular Diseases: Unlocking the Hidden Powerhouse of Cardiac Pathophysiology. Frontiers in Endocrinology, 16, Article 1617305. [Google Scholar] [CrossRef] [PubMed]
[5] 李文星, 张加廷, 李鑫, 等. 新型炎症标志物评分与STEMI患者预后及风险模型构建[J]. 医学研究杂志, 2024, 53(6): 124-130.
[6] Li, Q., Ma, X., Shao, Q., Yang, Z., Wang, Y., Gao, F., et al. (2022) Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients. Frontiers in Cardiovascular Medicine, 9, Article 811790. [Google Scholar] [CrossRef] [PubMed]
[7] Potempa, M., Hart, P.C., Rajab, I.M. and Potempa, L.A. (2025) Redefining CRP in Tissue Injury and Repair: More than an Acute Pro-Inflammatory Mediator. Frontiers in Immunology, 16, Article 1564607. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, C., Wu, R., Yang, H. and Yao, Y. (2025) Immune Cell Dynamics and Their Role in Cardiac Injury: Mechanisms and Therapeutic Implications. Biomedicine & Pharmacotherapy, 192, Article ID: 118608. [Google Scholar] [CrossRef
[9] Martín, P. and Sánchez-Madrid, F. (2025) T Cells in Cardiac Health and Disease. Journal of Clinical Investigation, 135, e185218. [Google Scholar] [CrossRef] [PubMed]
[10] Tao, Y., Liu, W., Yin, J., Chen, Z., Shen, Q. and Chen, L. (2026) Inflammatory Burden Index Is Associated with Increased Long-Term Risk of Major Advers Cardiovascular Events in Myocardial Infarction with Non-Obstructive Coronary Arteries. International Journal of General Medicine, 19, 1-10. [Google Scholar] [CrossRef
[11] 中国医师协会胸痛专业委员会, 编辑委员会中华心血管病杂志网络版, 急性心肌梗死后左心室重构防治专家共识起草组. 急性心肌梗死后左心室重构防治专家共识[J]. 中华心血管病杂志(网络版), 2020, 3(1): 17.
[12] Zhang, W., Peng, D., Cheng, S., Ni, R., Yang, M., Cai, Y., et al. (2025) Inflammatory Cell-Targeted Delivery Systems for Myocardial Infarction Treatment. Bioengineering, 12, Article 205. [Google Scholar] [CrossRef] [PubMed]
[13] Kostin, S., Krizanic, F., Kelesidis, T. and Pagonas, N. (2024) The Role of Netosis in Heart Failure. Heart Failure Reviews, 29, 1097-1106. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, Z., Wang, Y., Li, T. and Wang, H. (2025) Netosis in Myocardial Ischemiareperfusion Injury: From Mechanisms to Therapies (Review). Biomedical Reports, 23, 1-10. [Google Scholar] [CrossRef] [PubMed]
[15] Li, N., Hao, Z., Yang, H., Cai, J., Liu, M., He, J., et al. (2026) CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects against Myocardial Infarction-Induced Tissue Damage. Circulation, 153, 922-940. [Google Scholar] [CrossRef
[16] Mitsis, A., Sokratous, S., Karmioti, G., Kyriakou, M., Drakomathioulakis, M., Myrianthefs, M.M., et al. (2025) The Role of C-Reactive Protein in Acute Myocardial Infarction: Unmasking Diagnostic, Prognostic, and Therapeutic Insights. Journal of Clinical Medicine, 14, Article 4795. [Google Scholar] [CrossRef] [PubMed]
[17] Capone, F., Vacca, A., Bidault, G., Sarver, D., Kaminska, D., Strocchi, S., et al. (2025) Decoding the Liver-Heart Axis in Cardiometabolic Diseases. Circulation Research, 136, 1335-1362. [Google Scholar] [CrossRef] [PubMed]
[18] Dastjerdi, P., Mahalleh, M., Shayesteh, H., Najafi, M.S., Narimani-Javid, R., Dashtkoohi, M., et al. (2025) Liver Biomarkers as Predictors of Prognosis in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. BMC Cardiovascular Disorders, 25, Article No. 244. [Google Scholar] [CrossRef] [PubMed]